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OVEREXPRESSION OF hsa-miR-148A PROMOTES TYPE II COLLAGEN
SYNTHESIS BY OSTEOARTHRITIC CHONDROCYTES
L.A. Vonk1, A.H. Kragten1, D.B. Saris1, W.J. Dhert1,2, L.B. Creemers1. 1UMC
Utrecht, Utrecht, Netherlands; 2Univ. of Utrecht, Utrecht, Netherlands
Purpose: MicroRNAs (miRNAs) regulate gene expression through base-
speciﬁc interactions. The aim of this study was to further identify miRNAs
differentially expressed in OA and to investigate the effect of one of
these, miR-148, on the chondrogenic potential of chondrocytes from OA
cartilge.
Methods: Low-density Taqman arrays were used to identify miRNAs
differentially expressed in OA and normal cartilage. OA chondrocytes
were isolated from articular cartilage obtained from patients undergoing
knee arthroplasty. At passage 2, OA chondrocytes from 6 donors were
transfected with a miRNA precursor for hsa-miR-148a or a miRNA
precursor negative control. Chondrocytes were reverse-transfected
during seeding at high density (1.26×106 cells per cm2) on collagen-
coated culture inserts in a 96-wells transwell system. After 2 days,
real-time PCR was performed to examine gene expression levels of
aggrecan (ACAN), type I collagen (COL1A1), type II collagen (COL2A1) and
matrix metallopeptidase 13 (MMP13). After 1 week, glycosaminoglycan
(GAG), collagen and DNA content were determined using a DMMB,
hydroxyproline and Picogreen assay, respectively. Type II collagen was
analyzed at the protein level by Western blot.
Results: 66 miRNAs were differentially expressed in OA cartilage
compared to healthy cartilage, including miR-148a, which was
downregulated 11 times in OA cartilage compared to normal cartilage.
Overexpression of miR-148a had no effect on ACAN and COL1A1 gene
expression levels and on the amount of GAG produced by the cells.
MiR-148a overexpressed cells showed increased gene expression levels
of COL2A1, while MMP13 was decreased. The increase at the mRNA level
was reﬂected by an increase in the total amount of collagen, in particular
type II collagen as shown by biochemical analyses.
Conclusions: Several miRNAs are differentially expressed in OA and
modulating their expression may lead to a potential therapy for OA.
Overexpression of miR-148a increased type II collagen production by OA
chondrocytes.
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CHANGES IN GENE EXPRESSION WITH AGE AND OSTEOARTHRITIS
IN THE MOUSE KNEE JOINT
R. Loeser1, A. Olex1, M.A. McNulty2, C.S. Carlson3, M. Callahan1,
C. Ferguson1, J.S. Fetrow1. 1Wake Forest Univ., Winston Salem, NC, USA;
2Universtiy of Minnesota, St. Paul, MN, USA; 3Univ. of Minnesota, St. Paul,
MN, USA
Purpose: The mechanisms by which aging changes in the joint
predispose older adults to develop OA are incompletely understood.
The purpose of this study was to analyze differences in gene expression
between young and older adult mice to discover genes and biological
processes that contribute to age-related differences in the development
of OA in a joint injury model. The goal was to study changes in the joint
as an organ rather than study an individual tissue.
Methods: Young (12 week-old) and older (12 month-old) adult male
C57/BL6 mice underwent surgery to destabilize the medial meniscus
(DMM) or sham surgery as a control. 8 weeks after surgery, knee
joints from 6 mice in each age and surgical group were evaluated
histologically to measure OA severity and joints from 9 mice per group
were dissected to isolate RNA from the medial side of the joint (cartilage,
meniscus, subchondral bone and joint capsule with synovium) for gene
expression microarrays (triplicate arrays for each age and surgical group)
and real-time PCR. Computational analysis was performed to determine
changes occurring with age alone (sham knee comparisons) and with
the development of OA (signal log ratio comparisons of DMM/sham in
young vs old).
Results: Both young and older mice exhibited typical features of OA
in the DMM knees including cartilage surface ﬁbrillation and clefting,
osteophyte formation, and subchondral bone thickening which were
consistently more severe in the medial tibial plateau and were more
severe in the 12-month-old mice than in the 12-week-old mice. The
average articular cartilage structure score was about 2-fold greater in
the DMM knees of the older mice than in the younger mice. The sham
knees in the young mice were normal while in the older mice early
mild OA changes were noted. 861 genes showed age-related differences
in expression in the sham knees (430 up and 431 down in old) and
493 genes showed age-related differential expression in the DMM/sham
comparison while only 55 genes were expressed similarly in young
and older DMM/sham. DAVID analysis revealed that the set of genes
up-regulated with age in sham knees included immune response and
defense response (e.g. wound healing) genes. These included several
chemokine genes such as CXCL13, CCL8(MCP-2), CCL5(RANTES), CXCR2,
and CCR7. The genes down-regulated with age were related to metabolic
processes and the extracellular matrix including aggrecan, Col2a1, Col9a1,
Matn3, and Prkg2. However, opposite changes were noted in DMM knees
such that immune response genes were upregulated in young more than
old and matrix genes, including aggrecan, periostin and Col3 but not
Col2 increased more in the old than young. Genes such as IL-33, CCR7,
and DKK3 increased more in young. Only eight genes went down in
DMM knees in both age groups including complement factor D (adipsin)
and MUP1 while 47 genes went up in DMM knees of both age groups
including CCL21, IGF-1, and MMP-3.
Conclusions: When considering the joint as an organ, signiﬁcant age-
related differences in OA severity and in gene expression were noted in
the sham control knees and DMM knees of mice that can be used to
provide new insights into the effects of age on the development of OA.
Differences in expression of immune response genes, not expected in
OA, may be of particular interest. These genes went up with aging and
with induction of OA in young mice suggesting OA triggers an aging-like
response. The results also indicate that age is an important consideration
when using the DMM model in mice to study the role of a particular
gene in OA.
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NFAT3 SPECIFICALLY REGULATES MIR-140 TRANSCRIPTION IN
HUMAN OSTEOARTHRITIC CHONDROCYTES
G. Tardif, D. Hum, H. Fahmi, J-P. Pelletier, J. Martel-Pelletier. Osteoarthritis
Res. Unit, Univ. of Montreal Hosp. Res. Ctr. (CRCHUM), Montreal, QC,
Canada
Purpose: In osteoarthritis (OA), despite major progress regarding the
identiﬁcation and roles of catabolic mediators, further knowledge about
factors regulating their expression is needed. In this line of thought,
one recently identiﬁed class of molecules, the microRNA (miRNA), has
been found to add another level of regulation to gene expression
by down-regulating its target genes. The miRNA-140, present in an
intron of the WWP2 gene, is known to decrease the expression of
some genes that play detrimental roles in OA. However, the expression
level of miR-140 is signiﬁcantly decreased in human OA chondrocytes.
Therefore, understanding the transcriptional regulation of miR-140 is
of importance as it can provide a new basis for the rationalization
of a therapeutic strategy for this disease. We thus investigated the
transcriptional regulation of miR-140 in human OA chondrocytes.
Methods: Human OA chondrocyte gene and miRNA expression were
determined by quantitative PCR, gene silencing following cell transient
transfection with speciﬁc siRNAs, and miR-140 promoter activity
monitored by luciferase activity.
Results: In contrast to the signiﬁcantly reduced miR-140 expression
level in OA compared to normal chondrocytes, the expression of the
WWP2 was similar, suggesting that miR-140 has an additional level
of regulation. The DNA sequence upstream of miR-140 was found to
have promoter activity and predicted binding sites for NMP-4, MAZ and
NFAT. Gene silencing of MAZ, NMP4, NFAT1 and NFAT2 did not affect
miR-140 or WWP2 expression levels. However, silencing NFAT3 reduced
the miR-140 expression level but not that of WWP2, whereas silencing
NFAT5 reduced both miR-140 and WWP2 levels. Additional experiments
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performed on the cloned miR-140 promoter showed that silencing NFAT3
resulted in its decreased activity.
Conclusions: This is the ﬁrst study to provide evidence of an independent
regulatory mechanism of the intronic miR-140, which is speciﬁcally
regulated by NFAT3. Such knowledge is important and could open up
novel development avenues in therapeutic strategies targeting OA.
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EROSIVE THUMB BASE OSTEOARTHRITIS IN SYMPTOMATIC
COMMUNITY-DWELLING ADULTS: THE KEELE CLINICAL ASSESSMENT
STUDIES
W-Y. Kwok1, M. Kloppenburg1, M. Marshall2, E. Nicholls2,
F.R. Rosendaal3, D.A. van der Windt2, G. Peat2. 1Leiden Univ. Med. Ctr.,
Dept. of Rheumatology, Leiden, Netherlands; 2Arthritis Res. UK Primary
Care Ctr., Keele, North Staffordshire, United Kingdom; 3Leiden Univ. Med.
Ctr., Dept. of Clinical Epidemiology, Leiden, Netherlands
Purpose: Erosive osteoarthritis (EOA) is a subset of hand osteoarthritis
(HOA), deﬁned by radiographic erosions that are mostly present in
interphalangeal joints (IPJs). Data on the prevalence and clinical impact
of EOA in 1st carpometacarpal joints (CMCJ) are scarce. The aims were
to describe the frequency of erosions in 1stCMCJs in a community-based
population with hand symptoms and to explore the clinical impact of
EOA on clinical outcomes in comparison to inﬂammatory disease.
Methods: Postal questionnaires, standardised clinical assessments and
hand radiographs were completed in participants of two population-
based cohorts in North Staffordshire (CAS-K and CAS-HA), aged ≥50 years
who reported hand complaints lasting ≥1 day during past month.
EOA was deﬁned as the presence of eroded/remodeled phase in ≥1 IPJ
or 1st CMCJ (Verbruggen-Veys). Thumb base EOA was deﬁned as having
≥1 E- or R-phase in the 1stCMCJs.
Participants were categorized as having an inﬂammatory rheumatic
disease if they had a diagnosis in the general practice or local
rheumatology hospital medical records or if they had inﬂammatory
changes on the radiographs.
Self-reported hand pain/function was assessed with AUSCAN Pain and
Function subscales (ranges 0–20 and 0–36, respectively). Perceived
physical health status (physical component summary score, PCS) was
assessed with the SF-12 (range 0–100).
Prevalence of EOA in the population with hand symptoms was calculated
by dividing the number of persons with EOA by the sample size,
with 95% conﬁdence intervals (95%CI) based on a binomial distribution.
Mann-Whitney tests were used to test differences in outcomes between
participants with thumb EOA and radiographic non-erosive thumb base
OA. Linear regression analyses were used to estimate differences in
clinical outcomes between participants with and without EOA, adjusted
for age and sex.
Results: The population with hand complaints consisted of 1076
participants (60% women, mean age 64.7 years (SD 8.3). The prevalence of
EOA 1st CMCJs only was 4.0% (95%CI 2.6, 5.8), in IPJs/1st CMCJs combined
9.1% (95%CI 7.5, 11.0) and in IPJs only 15.2% (95%CI 12.1, 18.2).
EOA of 1st CMCJs was more often prevalent in men (4.9% vs. 3.5%),
whereas EOA of IPJs are more prevalent in women (7.3% vs. 19.2%).
No differences in AUSCAN Pain/Function subscales and PCS were seen
between persons symptomatic radiographic thumb base OA and thumb
base EOA (p-values 0.83, 0.70 and 0.47, respectively). Persons with EOA
scored signiﬁcantly worse than those without on AUSCAN Pain and
Function subscales (adjusted mean difference 1.1 (95%CI 0.2, 2.0) and 1.9
(95%CI 0.2, 3.7), respectively) and on PCS for physical health (adjusted
mean difference −0.6 (95%CI −1.1, −0.1). Persons with inﬂammatory
diseases (n = 44) scored worse on AUSCAN Pain and Function subscales
and PCS than persons with EOA (adjusted mean difference of 2.2 (95%CI
0.6, 3.8), 7.4 (95%CI 4.1, 10.7) and −9.0 (95%CI −13.3, −4.6), respectively.)
Conclusions: EOA of 1st CMCJs is more often prevalent in men than
women. EOA has a substantial impact on pain, function, and physical
health perceptions, although not as severe as persons with prevalent
inﬂammatory disease.
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COMPARATIVE ANALYSIS OF BONE EROSIONS AND CYSTS IN
RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND EROSIVE HAND
OSTEOARTHRITIS
S. Finzel1, C. Ernet1, C. Stach1, K. Engelke2, M. Englbrecht1, G. Schett1.
1Univ. Clinic of Erlangen-Nuremberg, Erlangen, Germany; 2Univ. of
Erlangen-Nuremberg, Erlangen, Germany
Purpose: To investigate the differences in the pattern of erosion
formation in patients with rheumatoid arthritis (RA), psoriatic arthritis
(PSA) and erosive hand osteoarthritis (EHOA) by a high-resolution
micro-computed tomography scanner (mCT) designed to visualize bone
architecture. RA, PSA and erosive hand osteoarthritis (EHOA) all lead
to joint destruction via formation of erosive lesions but may differ
substantially in their quality and distribution pattern.
Methods: 25 patients with RA, 25 patients with PSA and 25 patients age-
and sex-matched with EOHA received a micro-computed tomography
scan of the dominantly affected hand to compare structural bone changes
in the metacarpophalangeal joints. Number, size and distribution of bone
erosions and prevalence of cystic lesions were recorded, joint space
narrowing was measured
Results: The number of bone erosions was similar in RA, PSA and EHOA,
whereas their size was smaller in PSA and EHOA than in RA patients.
Moreover, erosions in EHOA showed a speciﬁc distribution pattern
affecting the ulnar and radial sites of the metacarpal heads (MCH).
Furthermore, in EHOA patients the preponderance of the affection of the
MCH as compared to the phalangeal bases was far more pronounced.
Cystic bone lesions, deﬁned as the absence of trabecular structure in a
circumscript area without cortical break were highly prevalent in EHOA
(92%) and were localized in peripheral and central subchondral areas
of periarticular bone, whereas they were signiﬁcantly less frequent in
RA (24%) and PSA (36%) (p < 0.01). Joint space narrowing was associated
with the presence of bone cysts and subchondral erosions. Higher age,
male sex and postmenopausal state were associated with bone cysts in
EOHA Patients.
Conclusions: High-resolution mCT imaging shows profound differences
in periarticular bone changes between RA, PSA and EOHA. The differential
pattern of erosive lesions and bone cysts in the three different forms of
arthritis and in particular the almost complete absence of bone cysts
in RA and PSA suggest different mechanisms to be involved in bone
remodelling in RA, PSA and EOHA. Our data indicate that it is possible
to differentiate between inﬂammatory- and degeneratively-triggered
erosion formation by advanced imaging technology.
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MRI IN HAND OSTEOARTHRITIS: VALIDATION OF THE OSLO HAND
OSTEOARTHRITIS MRI-SCORING METHOD AND ASSOCIATION WITH
PAIN
W-Y. Kwok1, M.C. Kortekaas1, M. Reijnierse2, D. van der Heijde1,3,
J.L. Bloem2, M. Kloppenburg1. 1Leiden Univ. Med. Ctr., Dept. of
Rheumatology, Leiden, Netherlands; 2Leiden Univ. Med. Ctr., Dept.
of Radiology, Leiden, Netherlands; 3Diakonhjemmet Hosp., Dept. of
Rheumatology, Oslo, Norway
Purpose: Hand osteoarthritis (OA) involves abnormalities in cartilage,
subchondral bone and synovium. Magnetic Resonance Imaging (MRI)
can visualise all these components at once, in contrast to conventional
radiographs or ultrasound (US). We aimed to investigate the
reproducibility of the newly developed Oslo Hand Osteoarthritis (OHOA)-
MRI scoring system and to validate it against other imaging modalities.
Furthermore, we associated MRI features in hand OA with pain and
investigated the presence of MRI features in different stages of hand
OA.
Methods: Sixteen patients (median age 57 years (range 42–71),
62% female) were recruited from the Rheumatology department of the
LUMC. Pain per joint (yes/no) was assessed for the distal and proximal
interphalangeal joints (DIPJs, PIPJs). MRI scans of 2nd-5th DIPJs and PIPJs of
the right hand were made, using a 3.0T MRI unit. Coronal and sagittal T1-
weigthed images pre-and post gadolinium contrast and fat-suppressed
T2-weigthed images were obtained. MRI features were scored according
to the OHOA-MRI scoring system (based on 1.0T images) for synovitis,
erosions, osteophytes (OP) and bone marrow lesions (BML) (grade 0–3).
Ultrasound was performed with a 10–14MHZ linear array transducer
and scored for greyscale synovitis and OP. Hand radiographs were scored
following the Verbruggen-Veys scoring method. An pre-erosive joint was
